T. Rowe Price Associates’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$337K Buy
36,811
+12,163
+49% +$102K ﹤0.01% 2631
2025
Q4
$184K Hold
24,648
﹤0.01% 2834
2025
Q3
$165K Buy
24,648
+1,963
+9% +$13.6K ﹤0.01% 2829
2025
Q2
$151K Buy
22,685
+5,276
+30% +$37.4K ﹤0.01% 2801
2025
Q1
$160K Buy
17,409
+2,215
+15% +$22.1K ﹤0.01% 2714
2024
Q4
$160K Buy
15,194
+3,153
+26% +$37.3K ﹤0.01% 2754
2024
Q3
$144K Hold
12,041
﹤0.01% 2755
2024
Q2
$0 Buy
+12,041
New +$66.1K ﹤0.01% 2941
2023
Q4
Sell
-62,679
Closed -$207K 2909
2023
Q3
$207K Buy
+62,679
New +$220K ﹤0.01% 2490
2021
Q4
Sell
-2,674,299
Closed -$37.9M 2987
2021
Q3
$37.9M Buy
+2,674,299
New +$41.2M ﹤0.01% 1110

Other funds holding BVS